ISTH 2020 Congress
Thrombotic Microangiopathies » ADAMTS13 and TTP
Theme Navigation
- ISTH 2020 Congress
- Thrombotic Microangiopathies
- ADAMTS13 and TTP
- Thrombotic Microangiopathies
-
Abstract Number: PB1882
Acquired Thrombotic Thrombocytopenic Purpura: Key Findings of Patients from Southern Italy
-
Abstract Number: OC 07.2
ADAMTS13 Conformation Is Closed in Acquired Thrombotic Thrombocytopenic Purpura in the Absence of Anti-ADAMTS13 Autoantibodies
-
Abstract Number: PB1885
Association of Plasmic Score with Neurological Symptoms in Patients with Thrombotic Thrombocytopenic Purpura (TTP)
-
Abstract Number: PB1862
Automated Chemiluminescent ADAMTS13 Activity Immunoassay for Thrombotic Thrombocytopenic Purpura Diagnosis and Follow-up
-
Abstract Number: PB1863
Caplacizumab in a Case of Acquired Thrombotic Thrombcytopenic Purpura (TTP) Poor Responsive to Plasma Exchange and Immunosuppressive Therapy
-
Abstract Number: PB1867
Clinical Analysis of 83 Patients with Thrombotic Thrombocytopenic Purpura
-
Abstract Number: PB1889
Clinical and Economic Impacts of a New Rapid ADAMTS-13 Assay for the Diagnosis of Suspected Thrombotic Thrombocytopenic Purpura
-
Abstract Number: PB1884
Correlation between Phenotype-genotype versus in-silico Prediction of Novel and Known Disease-causing Variants in Upshaw-Schulman Syndrome Patients in a Single Institution of Argentina
-
Abstract Number: PB1864
Current Possibilities of ADAMTS 13 Diagnostics – Advantages and Limitations
-
Abstract Number: PB1871
Development and Validation of a Prediction Model (AHC) for Early Identification of Refractory Thrombotic Thrombocytopenic Purpura Using Nationally Representative Data
-
Abstract Number: PB1857
Differential Diagnosis of Thrombotic Thrombocytopenic Purpura at Acute Phase by the Ratio of VWF Activity to VWF Antigen Based on Automatic Immunologic Assays
-
Abstract Number: PB1877
Efficacy of Preemptive Subcutaneous Rituximab in Immune-Mediated Thrombotic Thrombocytopenic Purpura: A Study of 12 Cases
-
Abstract Number: PB1888
Evaluation of a Rapid, Automated Chemiluminescent ADAMTS-13 Activity Assay for the ACL AcuStar
-
Abstract Number: PB1861
Exploration of Coagulation Disorders, von Willebrand Factor and ADAMTS13 in a Cohort of 45 Patients with Hemophagocytic Lymphohistiocytosis
-
Abstract Number: PB1874
Genetic Study of von Willebrand Factor Variants in Congenital Thrombotic Thrombocytopenic Purpura Patients
-
Abstract Number: PB1890
Genetic Variants in ADAMTS13 in Patients with Acquired TTP (aTTP)
-
Abstract Number: OC 07.1
How to Open ADAMTS13: An Integrative Approach to Build ADAMTS13 in Closed Conformation